Urodelia

  • Urodelia
    • Our vision and values
    • Our history and Identity
    • Our team
    • Our partnerships
    • Our commitments
    • Oncology activities
    • Research with nanoparticles
  • Animal health
    • For pets
    • UROELIA’s immuno oncology
    • Immuno oncology : scientific publications
  • Human health
    • Research in oncology
  • Press
  • Investors
  • Contact
Facebook
  • En
    • Fr

17th Annual Veterinary Vaccine Congress in Washington

by Urodelia on 18 February 2019
world-vaccine-congress-washington-2017

Urodelia is an invited speaker at the 17th Annual Veterinary Vaccine Congress in Washington, 10-12 april 2017

Urodelia’s presentation will be  about:

Developing a novel vaccine for therapeutic treatment of cancer in companion animals

–              Clinical data demonstrating the progress in adaptive immunotherapy for cancer in companion animals
–              Harnessing the ability of the immune system to eradicate cancer sharing on mechanism of action
–              Lessons learnt from developing an innovative and patented immunotherapy method to treat cancer in companion animals

Dr Patrick Frayssinet will present on day 2 in the veterinary section

http://www.terrapinn.com/conference/world-vaccine-congress-washington/Agenda-Day-2.stm

ESVONC CONGRESS LYON, France, 20-22th April 2017
Urodelia © 2019.
  • Facebook